TABLE 1.

Patient profile.

Number of patients	63
Mean age (year old)	13.5
Range of age (year old)	4 – 44
Proportion of male (%)	49.2
Sampled hemisphere. Number of patients (%)
Left alone	25 (39.7)
Right alone	28 (44.4)
Both	10 (15.9)
Seizure onset zone. Number of patients (%)
involving Frontal	12 (19.0)
involving Temporal	33 (52.4)
involving Parietal	16 (25.4)
involving Lateral-Occipital	4 (6.3)
Mean number of antiepileptic drugs	1.9
Antiepileptic drugs. Number of patients (%)
Carbamazepine (CBZ)	4 (6.3)
Oxcarbazepine (OXC)	30 (47.6)
Lacosamide (LCM)	20 (31.7)
Zonisamide (ZNS)	4 (6.3)
Phenytoin (PHT)	2 (3.2)
Lamotrigine (LTG)	18 (28.6)
Levetiracetam (LEV)	24 (38.1)
Valproate (VPA)	8 (12.7)
Clobazam (CLB)	5 (7.9)
Topiramate (TPM)	2 (3.2)
Etiology. Number of patients (%)
Tumor	12 (19.0)
Dysplasia	21 (33.3)
Hippocampal sclerosis	6 (9.5)
Dysplasia + Hippocampal sclerosis	1 (1.6)
No definitive lesion other than gliosis	22 (34.9)
Arteriovenous malformation	1 (1.6)

Ten patients had seizure onset zones involving at least two lobes.